Endothelial modulation of α1-adrenoceptor contractile responses in the tail artery of spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 765-771

  Tabernero, Antonia ^a   Giraldo, Jesús ^a   Vivas, Nuria María ^a   Badia, Albert ^a   Vila, Elisabet ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Endothelium; Hypertension; Tail artery; 3H prazosin binding; 1 adrenoceptors

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLEPHRINE; PRAZOSIN; TRITIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SMOOTH MUSCLE CONTRACTION; SPONTANEOUSLY HYPERTENSIVE RAT; TAIL ARTERY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0029858569     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15738.x     Document Type: Article

References (39)

1. ALOSACHIE, I. & GODFRAIND, T. (1988). The modulatory role of endothelium in the interaction of agonists and antagonists with α-adrenoceptors in the rat aorta. Br. J. Pharmacol., 95, 619-629.
2. ÄNGGARD, E. (1994). Nitric oxide: mediator, murdered and medicine. Lancet, 343, 1199-1205.
3. 1-adrenoceptor stimulation in spontaneously hypertensive rat caudal artery. J. Cardiovasc. Pharmacol., 95, 205 - 212.
4. 2-adrenoceptor for the field stimulation-induced neurogenic contraction of rat tail artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 601-616.
5. BLACK, J.W. & LEFF, P. (1983). Operational models of pharmacological agonism. Proc. R. Soc. Lond., B220, 141-162.
6. BLACK, J.W., LEFF, P., SHANKLEY, N.P. & WOOD, J. (1985). An operational model of pharmacological agonism: the effect of E/ [A] curve shape on agonist dissocìation constant estimation. Br. J. Pharmacol., 84, 561-571.
7. 2-adrenoceptors. J. Cardiovasc. Pharmacol., 11, 473-477.
8. DIXON, W.J. (1990). ed. BMDP Statistical Software. Berkeley, Los Angeles, London: University of California Press.
9. FLEMING, W.W., WESTFALL, D.P., DELALANDE, I.S. & JELLET, L.B. (1972). Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther., 181, 339-345.
10. FOUDA, A.K., KAUFMANN, A., THORIN, E., HENRION, D., CAPDEVILLE-ATKINSON, C. & ATKINSON, J. (1991). The role of endogenous norepinephrine release in potassium-evoked vasoconstriction of the rat tail artery. Eur. J. Pharmacol., 205, 63-72.
11. FURCHGOTT, R.F. (1966). The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in Drug Research, ed. Harper, N.J. & Simmonds, A.B. Vol. 3, pp. 21-55. New York: Academic Press.
12. GODFRAIND, T., EGLEME, C. & ALOSACHIE, I. (1985). Role of endothelium in the contractile response of rat aorta to α-adrenoceptor agonist. Clin. Sci., 68, (suppl 10), 655-715.
13. 2-adrenergic receptor mediated vasoconstriction in SHR tail arteries in vitro. Hypertension, 6, 112-118.
14. A): Directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation. J. Pharmacol. Exp. Ther., 249, 61-69.
15. KÜNG, C.F. & LÜSCHER, T.F. (1995). Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension, 25, 194-200.
16. LANG, M.G., NOLL, G. & LÜSCHER, T.F. (1995). Effect of aging and hypertension on contractility of resistance arteries: modulation by endothelial factors. Am. J. Physiol., 269, H837 - H841.
17. LEFF, P., PRENTICE, D.J., GILES, H., MARTIN, G.R. & WOOD, J. (1990). Estimation of agonist affinity and efficacy by direct, operational model-fitting. J. Pharmacol. Methods, 23, 225 - 237.
18. LI, X.F. & TRIGGLE, C.R. (1993). Effects of pertussis and cholera toxins on α-adrenoceptor function in rat tail artery: differences in hypertension. Can. J. Physiol. Pharmacol., 71, 791-799.
19. LITTELL, R.C., FREUND, R.J. & SPECTOR, P.C. (1991). SAS System for Linear Models. Cary N.C.: SAS Institute Inc.
20. LÜSCHER, T.F., DOHI, Y. & TSCHUDI, M. (1992). Endothelium-dependent regulation of resistance arteries alterations with aging and hypertension. J. Cardiovasc. Pharmacol., 19 (suppl. 5), S34 - S42.
21. MALTA, E., SCHINI, V. & MILLER, R.C. (1986). The role of efficacy in the assessment of the actions of α-adrenergic agonists in rat aorta with endothelium. J. Pharm. Pharmacol., 38, 209-213.
22. MARÍN, J. (1993). Mechanism involved in the increased vascular resistance in hypertension. J. Auton. Pharmacol., 13, 127-176.
23. MCPHERSON, G.A. (1983). A practical computer-based approach to the analysis of radioligand binding experiments. Computer. Progr. Biomed., 17, 107 - 113.
24. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. New Engl. J. Med., 329, 2002-2012.
25. MOREL, N. & GODFRAIND, T. (1991). Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine. Br. J. Pharmacol., 102, 467-477.
26. ORIOWO, M.A., BEVAN, R.D. & BEVAN, J.A. (1991). Variation in the interactions of some phenylethylamine and imidazoline derivatives with alpha-1 adrenoceptors in rabbit arteries: further evidence for the variable receptor affinity hypothesis. J. Pharmacol. Exp. Ther., 257, 651 - 656.
27. PARKER, R.B. & WAUD, D.R. (1971), Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther., 177, 1 - 12.
28. PERRY, P.A. & WEBB, R.C. (1988). Sensitivity and adrenoceptor affinity in the mesenteric artery of the deoxycorticosterone acetate hypertensive rat. Can. J. Physiol. Pharmacol., 66, 1095 - 1099.
29. 2-adrenoceptors of rat vas deferens using operational and null approaches. Eur. J. Pharmacol., 258, 229 - 238.
30. 2-adrenoceptors. Br. J. Pharmacol., 117, 1286 - 1292.
31. SÁNCHEZ-FERRER, C.F. & MARÍN, J. (1990). Endothelium-derived contractile factors. Gen. Pharmacol., 21, 589 - 603.
32. SEAGER, J.M., CLARK, A.H. & GARLAND, C.J. (1992). Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery. Br. J. Pharmacol., 105, 424 - 428.
33. 1-adrenoceptor-mediated responses in rat blood vessels. Br. J. Pharmacol., 117, 757 - 763.
34. TABERNERO, A. & VILA, E. (1995). Effect of age on noradrenaline response in rat tail artery and aorta: role of endothelium. J. Auton. Pharmacol., 15, 327 - 333.
35. THORIN-TRESCASES, N., HAMILTON, C.A., JARDINE, E. & REID, J.L. (1994). Signal transduction mechanisms of the vasoconstriction in hypertension. Eur. J. Pharmacol., 268, 199 - 207.
36. TOPOUZIS, S., SCHOTT, C. & STOCLET, J.C. (1991). Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by α-adrenoceptor agonists in rat aorta. J. Cardiovasc. Pharmacol., 18, 670 - 678.
37. 1-adrenoceptor in tail artery and aorta from spontaneously hypertensive and Wistar-Kyoto rats. J. Cardiovasc. Pharmacol., 22, 191 - 197.
38. 2-adrenoceptor agonist UK14304. Eur. J. Pharmacol., 196, 133 - 136.
39. YOKOTA, Y., IMAIZUMI, Y., ASANO, M., MATSUDA, T. & WATANABE, M. (1994). Endothelium-derived relaxing factor released by 5-HT: distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br. J. Pharmacol., 113, 324 - 330.